Dexcom Inc. Stock
Price
Target price
€75.03
€75.03
-1.700%
-1.3
-1.700%
€89.94
04.06.25 / Tradegate
WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Dexcom Inc. Stock
A loss of -1.700% shows a downward development for Dexcom Inc..
The stock is an absolute favorite of our community with 29 Buy predictions and no Sell predictions.
With a target price of 89 € there is a slightly positive potential of 18.62% for Dexcom Inc. compared to the current price of 75.03 €.
Our community identified positive and negative aspects for Dexcom Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Dexcom Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Dexcom Inc. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | -1.700% | -2.622% | 3.963% | -30.048% | -0.623% | 9.894% | -1.422% |
| Teleflex Inc. | -1.920% | -3.774% | -8.108% | -47.150% | -39.286% | -61.364% | -68.519% |
| Zimmer Holdings | 0.050% | -1.957% | -11.467% | -22.794% | -21.161% | -28.446% | -30.914% |
| Dentsply Sirona Inc. | 0.840% | -4.409% | 12.149% | -45.092% | -22.241% | -62.978% | -67.028% |
Comments
DexCom, Inc. (NASDAQ: DXCM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $104.00 price target on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Citigroup Inc. from $82.00 to $102.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) had its price target lowered by analysts at Piper Sandler from $100.00 to $90.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
News
Prediction: These 2 Stocks Will Beat the Market in the Next Decade
Investors typically want to beat the market over the long run. Though it's not an easy task, it certainly is possible with the right companies. Let's consider two corporations that could help you do
Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president, in addition to his current role as chief
DexCom Stock: Earnings Beat and New Market Access Drive Bull Case
DexCom, Inc. (NASDAQ: DXCM) has once again demonstrated its formidable position in the continuous glucose monitoring (CGM) market, delivering outstanding first-quarter 2025 financial results that
